Alan Bougen - Comvita Limited Insider

Comvita Limited -- USA Stock  

USD 5.99  0.00  0.00%

Non-Executive Deputy Chairman of the Board

Mr. Alan John Bougen is no longer a NonExecutive Deputy Chairman of the Board of Comvita Limited., effective October 2017. He having been a foundation Director since 1976 and serving as Managing Director until 1998. His background in the natural healthcare industry, apiculture and international marketing, brings a particularly pertinent industry and global perspective to the Board as Comvita continues in the developments of its key offshore markets. Alan is a member of the Institute of Directors and operates his own consultancy business which includes directorships in other private companies.
        
64 7 533 1426  http://www.comvita.co.nz

Management Efficiency

The company has return on total asset (ROA) of 0.25 % which means that it generated profit of $0.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 6.64 % meaning that it generated $6.64 on every $100 dollars invested by stockholders.
The company has accumulated 63.4 M in total debt with debt to equity ratio (D/E) of 46.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Comvita Limited has Current Ratio of 7.87 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 9 records

CHAIRMAN Since

Ramon TunezIndustria de Diseo Textil S A
N/A
Jianhong LiChina Merchants Bank Co Ltd
2014
Jianbo LiChina Merchants Bank Co Ltd
2014
Lirong XuChina Merchants Bank Co Ltd
2016
Santiago TrujilloInterconexin Elctrica S A E S P
2016
Moncef SlaouiGlaxoSmithKline plc
2014
Zehua MaChina Merchants Bank Co Ltd
2014
Jose SierraIndustria de Diseo Textil S A
2012
Pablo TejeraIndustria de Diseo Textil S A
2011

Entity Summary

Comvita Limited manufactures and markets natural health products. Comvita Limited was founded in 1974 and is headquartered in Te Puke, New Zealand. Comvita Limited operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market.Comvita Limited (CVNZF) is traded on OTC Market in USA. It is located in 23 Wilson Road South and employs 500 people.

Comvita Limited Leadership Team

Sarah Ottrey, Director
Simon Pothecary, Executive
Ben Shaw, Executive
Paul Reid, Director
Roy Ong, Executive
Patrick Brus, Executive
Alan Bougen, Chairman
Maurice Prendergast, Director
Scott Coulter, CEO
Lucas Bunt, Director
Murray Denyer, Director
Sharon Hollenstein, Executive
Brett Hewlett, CEO
Julianne Keast, CFO
Mark Sadd, Executive
Thomas Cullwick, Director
Neil Craig, Chairman
Kate Selway, Executive
Edward Quilty, Director
RalfChristian Schlothauer, Executive
MBA DipT, Executive
Sarah Kennedy, Director
Colin Baskin, Executive
Julie Chadwick, Executive

Stock Performance Indicators

Current Sentiment - CVNZF

Comvita Limited Investor Sentiment
Macroaxis portfolio users are unresponsive in their opinion about investing in Comvita Limited. What is your opinion about investing in Comvita Limited? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

BATS Exchange Efficient Frontier

Diversify in USA Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
Diversify Portfolios
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify Portfolios
Check also Trending Equities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.